Pyxis Oncology (NASDAQ:PYXS – Get Free Report) and Akebia Therapeutics (NASDAQ:AKBA – Get Free Report) are both small-cap medical companies, but which is the superior stock? ProfitabilityThis table compares Pyxis Oncology and Akebia Therapeutics’ net margins, return on equity and return on assets. Get Pyxis Oncology alerts:Net Margins Return on Equity Return on Assets Pyxis Oncology N/A -68.56% -52.14% Akebia Therapeutics -17.91% N/A -13.47%Earnings & ValuationThis table compares Pyxis Oncology and Akebia Therapeutics”s revenue, earnings per share and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Pyxis Oncology $2.82 million 48.38 -$77.33 million ($1.60) -1.38 Akebia Therapeutics $160.18 million 4.49 -$69.41 million ($0.17) -15.94Akebia Therapeutics has higher revenue and earnings than Pyxis Oncology. Given Pyxis Oncology’s higher possible upside, analysts clearly believe Pyxis Oncology is more favorable than Akebia Therapeutics.